Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice
Insulin resistance and type 2 diabetes are major risk factors for vascular complications. Vascular smooth muscle cells (VSMCs) derived from db/db mice, an established mouse model of type 2 diabetes, displayed enhanced inflammatory gene expression and proatherogenic responses. We examined the hypothe...
Gespeichert in:
Veröffentlicht in: | Circulation research 2008-09, Vol.103 (6), p.615-623 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 623 |
---|---|
container_issue | 6 |
container_start_page | 615 |
container_title | Circulation research |
container_volume | 103 |
creator | Reddy, Marpadga A Villeneuve, Louisa M Wang, Mei Lanting, Linda Natarajan, Rama |
description | Insulin resistance and type 2 diabetes are major risk factors for vascular complications. Vascular smooth muscle cells (VSMCs) derived from db/db mice, an established mouse model of type 2 diabetes, displayed enhanced inflammatory gene expression and proatherogenic responses. We examined the hypothesis that aberrant epigenetic chromatin events may the underlying mechanism for this persistent dysfunctional behavior and “memory” of the diabetic cells. Chromatin immunoprecipitation assays showed that levels of histone H3 lysine 4 dimethylation (H3K4me2), a key chromatin mark associated with active gene expression, were significantly elevated at the promoters of the inflammatory genes monocyte chemoattractant protein-1 and interleukin-6 in db/db VSMCs relative to db/+ cells. Tumor necrosis factor-α-induced inflammatory gene expression, H3K4me2 levels, and recruitment of RNA polymerase II at the gene promoters were also enhanced in db/db VSMCs, demonstrating the formation of open chromatin poised for transcriptional activation in diabetes. On the other hand, protein levels of lysine-specific demethylase1 (LSD1), which negatively regulates H3K4 methylation and its occupancy at these gene promoters, were significantly reduced in db/db VSMCs. High glucose (25 mmol/L) treatment of human VSMCs also increased inflammatory genes with parallel increases in promoter H3K4me2 levels and reduced LSD1 recruitment. LSD1 gene silencing with small interfering RNAs significantly increased inflammatory gene expression and enhanced VSMC-monocyte binding in nondiabetic VSMCs. In contrast, overexpression of LSD1 in diabetic db/db VSMCs inhibited their enhanced inflammatory gene expression. These results demonstrate novel functional roles for LSD1 and H3K4 methylation in VSMCs and inflammation. Dysregulation of their actions may be a major mechanism for vascular inflammation and metabolic memory associated with diabetic complications. |
doi_str_mv | 10.1161/CIRCRESAHA.108.175190 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2693400</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69556778</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5212-eaf0e42443a85075d65c95b70c7a9ec91d13ebaf545ce12a7c0a99408cb43c33</originalsourceid><addsrcrecordid>eNpVkl1v0zAUhiMEYmXwE0C5gbuU468kvkGqssEmdWJqJ24t1z0hBicudsJU8efx1mofV5aOn_PYPq-z7D2BOSEl-dxcrprV-XpxsZgTqOekEkTCi2xGBOUFFxV5mc0AQBYVY3CSvYnxFwDhjMrX2Qmpy7oGzmfZv5V3mPs2HzvMl_toByzWOzS2tSY_wx7Hbu90xJzkdriHroO3Q-t03-vRh31-3eHgx_3u3vJDRzM5HfJ17_3Y5VdTNMnfoHPxbv_M6g2OSX1lDb7NXrXaRXx3XE-zm6_nN81Fsfz-7bJZLAsjKKEF6haQU86ZrgVUYlsKI8WmAlNpiUaSLWG40a3gwiChujKgpeRQmw1nhrHT7MtBu5s2PW4NDmPQTu2C7XXYK6-ter4z2E799H8VLSXjAEnw6SgI_s-EcVS9jSY9SQ_op6hKKURZVXUCxQE0wccYsH04hIC6S009ppZKtTqklvo-PL3hY9cxpgR8PAJpvtq1QQ_GxgeOQllJScvE8QN3692IIf520y0G1aF2Y6fSdwAGaaIUoAZJKBSpQij7D2BIsok</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69556778</pqid></control><display><type>article</type><title>Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice</title><source>MEDLINE</source><source>American Heart Association</source><source>Journals@Ovid Complete</source><source>EZB Electronic Journals Library</source><creator>Reddy, Marpadga A ; Villeneuve, Louisa M ; Wang, Mei ; Lanting, Linda ; Natarajan, Rama</creator><creatorcontrib>Reddy, Marpadga A ; Villeneuve, Louisa M ; Wang, Mei ; Lanting, Linda ; Natarajan, Rama</creatorcontrib><description>Insulin resistance and type 2 diabetes are major risk factors for vascular complications. Vascular smooth muscle cells (VSMCs) derived from db/db mice, an established mouse model of type 2 diabetes, displayed enhanced inflammatory gene expression and proatherogenic responses. We examined the hypothesis that aberrant epigenetic chromatin events may the underlying mechanism for this persistent dysfunctional behavior and “memory” of the diabetic cells. Chromatin immunoprecipitation assays showed that levels of histone H3 lysine 4 dimethylation (H3K4me2), a key chromatin mark associated with active gene expression, were significantly elevated at the promoters of the inflammatory genes monocyte chemoattractant protein-1 and interleukin-6 in db/db VSMCs relative to db/+ cells. Tumor necrosis factor-α-induced inflammatory gene expression, H3K4me2 levels, and recruitment of RNA polymerase II at the gene promoters were also enhanced in db/db VSMCs, demonstrating the formation of open chromatin poised for transcriptional activation in diabetes. On the other hand, protein levels of lysine-specific demethylase1 (LSD1), which negatively regulates H3K4 methylation and its occupancy at these gene promoters, were significantly reduced in db/db VSMCs. High glucose (25 mmol/L) treatment of human VSMCs also increased inflammatory genes with parallel increases in promoter H3K4me2 levels and reduced LSD1 recruitment. LSD1 gene silencing with small interfering RNAs significantly increased inflammatory gene expression and enhanced VSMC-monocyte binding in nondiabetic VSMCs. In contrast, overexpression of LSD1 in diabetic db/db VSMCs inhibited their enhanced inflammatory gene expression. These results demonstrate novel functional roles for LSD1 and H3K4 methylation in VSMCs and inflammation. Dysregulation of their actions may be a major mechanism for vascular inflammation and metabolic memory associated with diabetic complications.</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/CIRCRESAHA.108.175190</identifier><identifier>PMID: 18688044</identifier><identifier>CODEN: CIRUAL</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>Animals ; Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Diabetes Mellitus, Type 2 - enzymology ; Diabetes Mellitus, Type 2 - genetics ; Diabetes Mellitus, Type 2 - pathology ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Fundamental and applied biological sciences. Psychology ; Histone Demethylases ; Histones - metabolism ; Humans ; Inflammation Mediators - physiology ; Lysine - metabolism ; Male ; Medical sciences ; Methylation ; Mice ; Mice, Knockout ; Mice, Mutant Strains ; Muscle, Smooth, Vascular - enzymology ; Muscle, Smooth, Vascular - pathology ; Myocytes, Smooth Muscle - enzymology ; Myocytes, Smooth Muscle - pathology ; Oxidoreductases, N-Demethylating - metabolism ; Oxidoreductases, N-Demethylating - physiology ; Phenotype ; Vertebrates: cardiovascular system</subject><ispartof>Circulation research, 2008-09, Vol.103 (6), p.615-623</ispartof><rights>2008 American Heart Association, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5212-eaf0e42443a85075d65c95b70c7a9ec91d13ebaf545ce12a7c0a99408cb43c33</citedby><cites>FETCH-LOGICAL-c5212-eaf0e42443a85075d65c95b70c7a9ec91d13ebaf545ce12a7c0a99408cb43c33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,3673,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20679926$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18688044$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reddy, Marpadga A</creatorcontrib><creatorcontrib>Villeneuve, Louisa M</creatorcontrib><creatorcontrib>Wang, Mei</creatorcontrib><creatorcontrib>Lanting, Linda</creatorcontrib><creatorcontrib>Natarajan, Rama</creatorcontrib><title>Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice</title><title>Circulation research</title><addtitle>Circ Res</addtitle><description>Insulin resistance and type 2 diabetes are major risk factors for vascular complications. Vascular smooth muscle cells (VSMCs) derived from db/db mice, an established mouse model of type 2 diabetes, displayed enhanced inflammatory gene expression and proatherogenic responses. We examined the hypothesis that aberrant epigenetic chromatin events may the underlying mechanism for this persistent dysfunctional behavior and “memory” of the diabetic cells. Chromatin immunoprecipitation assays showed that levels of histone H3 lysine 4 dimethylation (H3K4me2), a key chromatin mark associated with active gene expression, were significantly elevated at the promoters of the inflammatory genes monocyte chemoattractant protein-1 and interleukin-6 in db/db VSMCs relative to db/+ cells. Tumor necrosis factor-α-induced inflammatory gene expression, H3K4me2 levels, and recruitment of RNA polymerase II at the gene promoters were also enhanced in db/db VSMCs, demonstrating the formation of open chromatin poised for transcriptional activation in diabetes. On the other hand, protein levels of lysine-specific demethylase1 (LSD1), which negatively regulates H3K4 methylation and its occupancy at these gene promoters, were significantly reduced in db/db VSMCs. High glucose (25 mmol/L) treatment of human VSMCs also increased inflammatory genes with parallel increases in promoter H3K4me2 levels and reduced LSD1 recruitment. LSD1 gene silencing with small interfering RNAs significantly increased inflammatory gene expression and enhanced VSMC-monocyte binding in nondiabetic VSMCs. In contrast, overexpression of LSD1 in diabetic db/db VSMCs inhibited their enhanced inflammatory gene expression. These results demonstrate novel functional roles for LSD1 and H3K4 methylation in VSMCs and inflammation. Dysregulation of their actions may be a major mechanism for vascular inflammation and metabolic memory associated with diabetic complications.</description><subject>Animals</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Diabetes Mellitus, Type 2 - enzymology</subject><subject>Diabetes Mellitus, Type 2 - genetics</subject><subject>Diabetes Mellitus, Type 2 - pathology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Histone Demethylases</subject><subject>Histones - metabolism</subject><subject>Humans</subject><subject>Inflammation Mediators - physiology</subject><subject>Lysine - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methylation</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Mice, Mutant Strains</subject><subject>Muscle, Smooth, Vascular - enzymology</subject><subject>Muscle, Smooth, Vascular - pathology</subject><subject>Myocytes, Smooth Muscle - enzymology</subject><subject>Myocytes, Smooth Muscle - pathology</subject><subject>Oxidoreductases, N-Demethylating - metabolism</subject><subject>Oxidoreductases, N-Demethylating - physiology</subject><subject>Phenotype</subject><subject>Vertebrates: cardiovascular system</subject><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkl1v0zAUhiMEYmXwE0C5gbuU468kvkGqssEmdWJqJ24t1z0hBicudsJU8efx1mofV5aOn_PYPq-z7D2BOSEl-dxcrprV-XpxsZgTqOekEkTCi2xGBOUFFxV5mc0AQBYVY3CSvYnxFwDhjMrX2Qmpy7oGzmfZv5V3mPs2HzvMl_toByzWOzS2tSY_wx7Hbu90xJzkdriHroO3Q-t03-vRh31-3eHgx_3u3vJDRzM5HfJ17_3Y5VdTNMnfoHPxbv_M6g2OSX1lDb7NXrXaRXx3XE-zm6_nN81Fsfz-7bJZLAsjKKEF6haQU86ZrgVUYlsKI8WmAlNpiUaSLWG40a3gwiChujKgpeRQmw1nhrHT7MtBu5s2PW4NDmPQTu2C7XXYK6-ter4z2E799H8VLSXjAEnw6SgI_s-EcVS9jSY9SQ_op6hKKURZVXUCxQE0wccYsH04hIC6S009ppZKtTqklvo-PL3hY9cxpgR8PAJpvtq1QQ_GxgeOQllJScvE8QN3692IIf520y0G1aF2Y6fSdwAGaaIUoAZJKBSpQij7D2BIsok</recordid><startdate>20080912</startdate><enddate>20080912</enddate><creator>Reddy, Marpadga A</creator><creator>Villeneuve, Louisa M</creator><creator>Wang, Mei</creator><creator>Lanting, Linda</creator><creator>Natarajan, Rama</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080912</creationdate><title>Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice</title><author>Reddy, Marpadga A ; Villeneuve, Louisa M ; Wang, Mei ; Lanting, Linda ; Natarajan, Rama</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5212-eaf0e42443a85075d65c95b70c7a9ec91d13ebaf545ce12a7c0a99408cb43c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Diabetes Mellitus, Type 2 - enzymology</topic><topic>Diabetes Mellitus, Type 2 - genetics</topic><topic>Diabetes Mellitus, Type 2 - pathology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Histone Demethylases</topic><topic>Histones - metabolism</topic><topic>Humans</topic><topic>Inflammation Mediators - physiology</topic><topic>Lysine - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methylation</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Mice, Mutant Strains</topic><topic>Muscle, Smooth, Vascular - enzymology</topic><topic>Muscle, Smooth, Vascular - pathology</topic><topic>Myocytes, Smooth Muscle - enzymology</topic><topic>Myocytes, Smooth Muscle - pathology</topic><topic>Oxidoreductases, N-Demethylating - metabolism</topic><topic>Oxidoreductases, N-Demethylating - physiology</topic><topic>Phenotype</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reddy, Marpadga A</creatorcontrib><creatorcontrib>Villeneuve, Louisa M</creatorcontrib><creatorcontrib>Wang, Mei</creatorcontrib><creatorcontrib>Lanting, Linda</creatorcontrib><creatorcontrib>Natarajan, Rama</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reddy, Marpadga A</au><au>Villeneuve, Louisa M</au><au>Wang, Mei</au><au>Lanting, Linda</au><au>Natarajan, Rama</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice</atitle><jtitle>Circulation research</jtitle><addtitle>Circ Res</addtitle><date>2008-09-12</date><risdate>2008</risdate><volume>103</volume><issue>6</issue><spage>615</spage><epage>623</epage><pages>615-623</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><coden>CIRUAL</coden><abstract>Insulin resistance and type 2 diabetes are major risk factors for vascular complications. Vascular smooth muscle cells (VSMCs) derived from db/db mice, an established mouse model of type 2 diabetes, displayed enhanced inflammatory gene expression and proatherogenic responses. We examined the hypothesis that aberrant epigenetic chromatin events may the underlying mechanism for this persistent dysfunctional behavior and “memory” of the diabetic cells. Chromatin immunoprecipitation assays showed that levels of histone H3 lysine 4 dimethylation (H3K4me2), a key chromatin mark associated with active gene expression, were significantly elevated at the promoters of the inflammatory genes monocyte chemoattractant protein-1 and interleukin-6 in db/db VSMCs relative to db/+ cells. Tumor necrosis factor-α-induced inflammatory gene expression, H3K4me2 levels, and recruitment of RNA polymerase II at the gene promoters were also enhanced in db/db VSMCs, demonstrating the formation of open chromatin poised for transcriptional activation in diabetes. On the other hand, protein levels of lysine-specific demethylase1 (LSD1), which negatively regulates H3K4 methylation and its occupancy at these gene promoters, were significantly reduced in db/db VSMCs. High glucose (25 mmol/L) treatment of human VSMCs also increased inflammatory genes with parallel increases in promoter H3K4me2 levels and reduced LSD1 recruitment. LSD1 gene silencing with small interfering RNAs significantly increased inflammatory gene expression and enhanced VSMC-monocyte binding in nondiabetic VSMCs. In contrast, overexpression of LSD1 in diabetic db/db VSMCs inhibited their enhanced inflammatory gene expression. These results demonstrate novel functional roles for LSD1 and H3K4 methylation in VSMCs and inflammation. Dysregulation of their actions may be a major mechanism for vascular inflammation and metabolic memory associated with diabetic complications.</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>18688044</pmid><doi>10.1161/CIRCRESAHA.108.175190</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7330 |
ispartof | Circulation research, 2008-09, Vol.103 (6), p.615-623 |
issn | 0009-7330 1524-4571 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2693400 |
source | MEDLINE; American Heart Association; Journals@Ovid Complete; EZB Electronic Journals Library |
subjects | Animals Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Diabetes Mellitus, Type 2 - enzymology Diabetes Mellitus, Type 2 - genetics Diabetes Mellitus, Type 2 - pathology Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Fundamental and applied biological sciences. Psychology Histone Demethylases Histones - metabolism Humans Inflammation Mediators - physiology Lysine - metabolism Male Medical sciences Methylation Mice Mice, Knockout Mice, Mutant Strains Muscle, Smooth, Vascular - enzymology Muscle, Smooth, Vascular - pathology Myocytes, Smooth Muscle - enzymology Myocytes, Smooth Muscle - pathology Oxidoreductases, N-Demethylating - metabolism Oxidoreductases, N-Demethylating - physiology Phenotype Vertebrates: cardiovascular system |
title | Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T16%3A42%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20the%20Lysine-Specific%20Demethylase%201%20in%20the%20Proinflammatory%20Phenotype%20of%20Vascular%20Smooth%20Muscle%20Cells%20of%20Diabetic%20Mice&rft.jtitle=Circulation%20research&rft.au=Reddy,%20Marpadga%20A&rft.date=2008-09-12&rft.volume=103&rft.issue=6&rft.spage=615&rft.epage=623&rft.pages=615-623&rft.issn=0009-7330&rft.eissn=1524-4571&rft.coden=CIRUAL&rft_id=info:doi/10.1161/CIRCRESAHA.108.175190&rft_dat=%3Cproquest_pubme%3E69556778%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69556778&rft_id=info:pmid/18688044&rfr_iscdi=true |